$54.24
-0.75-1.36%
At close: -
$54.24
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
PTC Therapeutics Stock Guidance | NASDAQ:PTCT | Benzinga
PTC Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $600.00M | $800.00M | $891.17M | Get Alert |
| 01/13/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $600.00M | $800.00M | $963.31M | Get Alert |
| 01/13/2025 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $814.00M | $814.00M | $795.38M | Get Alert |
| 11/07/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $750.00M | $800.00M | $734.43M | Get Alert |
| 08/08/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $700.00M | $750.00M | $749.22M | Get Alert |
| 04/25/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $600.00M | $680.00M | $606.63M | Get Alert |
| 02/29/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $600.00M | $680.00M | $612.29M | Get Alert |
| 01/08/2024 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $946.00M | $946.00M | $936.85M | Get Alert |
| 01/08/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $600.00M | $850.00M | $652.89M | Get Alert |
| 10/26/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $938.32M | Get Alert |
| 08/03/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $962.16M | Get Alert |
| 07/19/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $961.42M | Get Alert |
| 04/27/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $866.89M | Get Alert |
| 02/21/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $898.56M | Get Alert |
| 01/09/2023 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $710.00M | $710.00M | $729.36M | Get Alert |
| 01/09/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $865.56M | Get Alert |
| 10/27/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $710.00M | $750.00M | $726.44M | Get Alert |
| 08/04/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $722.95M | Get Alert |
| 05/03/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $721.44M | Get Alert |
| 02/22/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $715.53M | Get Alert |
| 01/10/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $654.44M | Get Alert |
FAQ
What is the most recent guidance for PTC Therapeutics (PTCT)?
There have been no specific sales or earnings guidance reported for PTC Therapeutics in recent months.
Browse guidance and forecast on all stocks.